We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Emergent BioSolutions Awarded $19.7 Million BARDA Contract

News   Jul 24, 2015

 
Emergent BioSolutions Awarded $19.7 Million BARDA Contract
 
 
Advertisement
 

RELATED ARTICLES

Rewriting the Rules of Vaccine Design With DNA Origami

News

By folding DNA into a virus-like structure, MIT researchers have designed HIV-like particles that provoke a strong immune response from human immune cells grown in a lab dish. Such particles might eventually be used as an HIV vaccine.

READ MORE

Designer Peptides Can Bind and Block Viruses

News

Chemically engineered peptides could prove valuable in the battle against some of the most persistent human health challenges, such as viral infection.

READ MORE

Spurring the Production of New Antibiotics Hiding in Bacterial Genomes

News

Researchers have developed a method to spur the production of new antibiotic or antiparasitic compounds hiding in the genomes of actinobacteria, which are the source of drugs such as actinomycin and streptomycin and are known to harbor other untapped chemical riches.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE